Display Settings:

Format

Send to:

Choose Destination
    Stereotact Funct Neurosurg. 2000;75(4):167-75.

    Continuous intrathecal clonidine administration for the treatment of neuropathic pain.

    Source

    Department of Neurosurgery, Philipps University Marburg, Germany. anthogal@mailer.uni-marburg.de

    Abstract

    In many cases, the treatment of neuropathic pain by intrathecal opioids fails to meet expectations. In a trial involving 10 patients, the intrathecal administration of clonidine combined with opioids in the treatment of chronic pain was introduced in our department for the first time. Eight patients with neuropathic pain syndromes were subjected to a continuous intrathecal clonidine application in addition to intrathecal morphine. At an average dose of 44 microg clonidine/day, a 70-100% reduction in pain was achieved. Residual non-neuropathic pain in 4 of 8 patients was successfully treated with clonidine and low doses of opioids. On the basis of the results achieved so far, we recommend that clonidine should be routinely tested for intrathecal drug administration, especially in patients with a prominent neuropathic pain component.

    Copyright 2002 S. Karger AG, Basel

    PMID:
    11910210
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk